Neovascularization and oxidative stress in the progression of non-alcoholic steatohepatitis

Molecular Medicine Reports

Volumn 1, Issue 4, 2008, Pages 543-548

  Kitade, Mitsuteru ^a   Yoshiji, Hitoshi ^a   Kojima, Hideyuki ^a   Ikenaka, Yasuhide ^a   Noguchi, Ryuichi ^a   Kaji, Kosuke ^a   Yoshii, Junichi ^a   Yanase, Koji ^a   Namisaki, Tadashi ^a   Yamazaki, Masaharu ^a   Tsujimoto, Tatsuhiro ^a   Moriya, Kei ^a   Kawaratani, Hideto ^a   Akahane, Takemi ^a   Fukui, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Liver fibrosis; Non alcoholic steatohepatitis; Oxidative stress

Indexed keywords

4 HYDROXYNONENAL; CD34 ANTIGEN; HYALURONIC ACID DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FATTY LIVER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LIPID PEROXIDATION; LIVER BIOPSY; LIVER FIBROSIS; MALE; NEOVASCULARIZATION (PATHOLOGY); NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS;

RATTUS;

EID: 69249105379     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.1.4.543     Document Type: Article

References (33)

1. Angulo P: Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231, 2002.
2. Reid AE: Nonalcoholic steatohepatitis. Gastroenterology 121: 710-723, 2001.
3. Jaeschke H: Reactive oxygen and mechanisms of inflammatory liver injury. J Gastroenterol Hepatol 15: 718-724, 2000. (Pubitemid 30615053)
4. Sato N: Central role of mitochondria in metabolic regulation of liver pathophysiology. J Gastroenterol Hepatol 22 (suppl 1): 1-6, 2007.
5. Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K and Wakasa K: In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 37: 56-62, 2002.
6. Gao D, Wei C, Chen L, Huang J, Yang S and Diehl AM: Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease. Am J Physiol Gastrointest Liver Physiol 287: G1070-G1077, 2004. (Pubitemid 39423700)
7. Carmeliet P: Angiogenesis in life, disease and medicine. Nature 438: 932-936, 2005.
8. Kalluri R and Sukhatme VP: Fibrosis and angiogenesis. Curr Opin Nephrol Hypertens 9: 413-418, 2000.
9. Yoshiji H, Kuriyama S, Yoshii J, et al: Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut 52: 1347-1354, 2003. (Pubitemid 37026470)
10. Medina J, Caveda L, Sanz-Cameno P, et al: Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis. J Hepatol 38: 660-667, 2003. (Pubitemid 36560652)
11. Shibuya M: Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct 26: 25-35, 2001. (Pubitemid 32421949)
12. Corpechot C, Barbu V, Wendum D, et al: Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 35: 1010-1021, 2002. (Pubitemid 34453998)
13. Salcedo X, Medina J, Sanz-Cameno P, et al: The potential of angiogenesis soluble markers in chronic hepatitis C. Hepatology 42: 696-701, 2005. (Pubitemid 41233664)
14. Nakamura K, Zen Y, Sato Y, et al: Vascular endothelial growth factor, its receptor Flk-1, and hypoxia inducible factor-1alpha are involved in malignant transformation in dysplastic nodules of the liver. Hum Pathol 38: 1532-1546, 2007. (Pubitemid 47418965)
15. Kitade M, Yoshiji H, Kojima H, et al: Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats. Hepatology 44: 983-991, 2006. (Pubitemid 46489563)
16. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L and Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432, 1994. (Pubitemid 24365442)
17. Yamauchi T, Kamon J, Ito Y, et al: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769, 2003. (Pubitemid 36735700)
18. The French METAVIR Cooperative Study Group: Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20: 15-20, 1994.
19. Di Carlo I, Fraggetta F, Lombardo R, Azzarello G, Vasquez E and Puleo S: CD 34 expression in chronic and neoplastic liver diseases. Panminerva Med 44: 365-367, 2002. (Pubitemid 41328283)
20. Yoshiji H, Kuriyama S, Yoshii J, et al: Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma. Hepatology 35: 834-842, 2002. (Pubitemid 34258377)
21. Pessayre D, Mansouri A and Fromenty B: Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol 282: G193-G199, 2002. (Pubitemid 34651674)
22. Kojima H, Sakurai S, Uemura M, Fukui H, Morimoto H and Tamagawa Y: Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis. Alcohol Clin Exp Res 31: S61-S66, 2007. (Pubitemid 46114917)
23. Yang S, Zhu H, Li Y, et al: Mitochondrial adaptations to obesity-related oxidant stress. Arch Biochem Biophys 378: 259-268, 2000. (Pubitemid 30397626)
24. Park YN, Yang CP, Fernandez GJ, Cubukcu O, Thung SN and Theise ND: Neoangiogenesis and sinusoidal 'capillarization' in dysplastic nodules of the liver. Am J Surg Pathol 22: 656-662, 1998.
25. Theuerkauf I, Zhou H and Fischer HP: Immunohistochemical patterns of human liver sinusoids under different conditions of pathologic perfusion. Virchows Arch 438: 498-504, 2001. (Pubitemid 32449059)
26. Marra F, Aleffi S, Bertolani C, Petrai I and Vizzutti F: Adipokines and liver fibrosis. Eur Rev Med Pharmacol Sci 9: 279-284, 2005.
27. Larter CZ and Farrell GC: Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat? J Hepatol 44: 253-261, 2006.
28. Leclercq IA, Farrell GC, Schriemer R and Robertson GR: Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol 37: 206-213, 2002. (Pubitemid 34833082)
29. Musso G, Gambino R, Biroli G, et al: Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol 100: 2438-2446, 2005. (Pubitemid 43919675)
30. Kamada Y, Tamura S, Kiso S, et al: Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 125: 1796 - 1807, 2003.
31. Honda H, Ikejima K, Hirose M, et al: Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology 36: 12-21, 2002. (Pubitemid 34700757)
32. Saxena NK, Ikeda K, Rockey DC, Friedman SL and Anania FA: Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 35: 762-771, 2002. (Pubitemid 34258369)
33. Sierra-Honigmann MR, Nath AK, Murakami C, et al: Biological action of leptin as an angiogenic factor. Science 281: 1683-1686, 1998. (Pubitemid 28435586)